UBS Group AG - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 67 filers reported holding LUX HEALTH TECH ACQUISITION in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 1.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q3 2022$48,000
-21.3%
4,781
-22.4%
0.00%
Q2 2022$61,000
-10.3%
6,158
-11.5%
0.00%
Q1 2022$68,000
+74.4%
6,956
+71.6%
0.00%
Q4 2021$39,000
-4.9%
4,053
-4.7%
0.00%
Q3 2021$41,000
-32.8%
4,252
-30.9%
0.00%
Q2 2021$61,000
-14.1%
6,152
-11.6%
0.00%
Q1 2021$71,0006,9580.00%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 1,700,000$16,813,00084.84%
MYDA Advisors LLC 900,000$8,901,0002.49%
Empyrean Capital Partners, LP 3,000,649$29,676,0000.94%
Tuttle Capital Management, LLC 30,166$298,0000.83%
Silver Rock Financial LP 369,442$3,654,0000.80%
BBR PARTNERS, LLC 639,999$6,330,0000.74%
Governors Lane LP 725,000$7,170,0000.57%
Mint Tower Capital Management B.V. 606,757$6,001,0000.48%
Spartan Fund Management Inc. 226,753$2,243,0000.48%
Privium Fund Management (UK) Ltd 40,353$399,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders